PO.PS01.01 · 人群科学
丰富的健康间质对乳腺癌的保护作用:Susan G. Komen组织库中健康女性的前瞻性队列研究
Protective role of abundant healthy stroma against breast cancer: A prospective cohort study of healthy women in the Susan G. Komen Tissue Bank
该海报暂无可下载的资料
AACR 官方页面
作者与单位 Authors & Affiliations
摘要 Abstract
中文摘要
背景
乳腺癌(BC)仍然是全球女性发病和死亡的主要原因之一。为遏制这一趋势,未来的乳腺癌风险降低策略需要以乳腺癌的病因组织发生学为基础,即正常乳腺中病因因素影响乳腺癌风险的组织通路。既往研究结果表明,乳腺的组织构成可能为乳腺癌的病因组织发生学提供线索。然而,许多既往研究是在患有良性乳腺疾病(BBD)的女性中开展的,这是一种以潜在病理改变为特征的组织状态,可能会干扰对病因组织发生学的研究。在此,我们研究了正常乳腺的组织学组织构成指标与后续乳腺癌风险之间的关联。
方法
这项前瞻性队列研究纳入了3,435名健康女性(年龄18-75岁),她们在2009-2019年间向Susan G. Komen组织库(KTB)捐赠了正常乳腺组织并符合研究特定的纳入标准。其中,109名女性在中位随访6年(范围:1-16年)后发生乳腺癌。采用有监督的机器学习算法分析正常乳腺组织的数字化组织学切片,为每名女性生成上皮、间质和脂肪组织百分比的定量数据。在以年龄为时间尺度的多变量Cox比例风险回归模型中评估组织学指标与乳腺癌发病之间的关联。分析既进行了总体分析,也按研究入组时的年龄和绝经状态进行了分层。模型对种族、教育程度、产次、体重指数、吸烟状态、饮酒和全切片组织面积进行了校正。
结果
总体而言,丰富的间质与乳腺癌风险降低相关(每增加1个标准差(SD)的风险比(HR)=0.55,95%置信区间[CI]=0.38至0.80,P<0.01)。间质的保护作用在组织捐赠时年龄小于55岁的女性中最为显著(HR/1-SD=0.45,95% CI=0.26至0.79,P<0.01),以及在绝经前女性中(HR/1-SD=0.48,95% CI=0.26至0.87,P=0.015),无论年龄如何。上皮和脂肪组织升高与这些相同组别中显著增加的乳腺癌风险相关。然而,当将间质和脂肪组织纳入同一回归模型时,对间质组织的相互校正减弱了脂肪相关风险,包括总体女性(HR/1-SD=0.26,95% CI=0.06至1.16,P=0.077)、年龄小于55岁的女性(HR/1-SD=0.17,95% CI=0.04至0.71,P=0.015)以及绝经前女性(HR/1-SD=0.16,95% CI=0.04至0.65,P=0.01)。
结论
这项健康女性队列的研究结果为间质在正常稳态期间乳腺癌组织发生中的作用提供了见解,对乳腺癌风险预测和风险降低策略具有潜在意义。
查看英文原文 English abstract
Background
Breast cancer (BC) remains a leading cause of morbidity and mortality in women worldwide. To mitigate this trend, future BC risk reduction strategies need to be grounded in BC etiologic histogenesis, i.e., the tissue pathways in the normal breast by which etiologic factors impact BC risk. Results from previous studies have indicated that the tissue composition of the breast may offer clues into the etiologic histogenesis of BC. However, many prior studies were conducted among women with benign breast disease (BBD), a tissue state characterized by underlying pathological changes that may obscure studies of etiologic histogenesis. Here, we investigated the associations of histologic tissue composition metrics of the normal breast with subsequent BC risk.
Methods
This prospective cohort study includes 3,435 healthy females (aged 18-75 years) who donated normal breast tissue to the Susan G. Komen Tissue Bank (KTB) between 2009-2019 and met study-specific inclusion criteria. Of these, 109 women developed BC after a median follow-up of 6 years (range: 1-16 years). Supervised machine-learning algorithms were used to analyze digitized histologic sections of normal breast tissues to generate quantitative data on percent epithelium, stroma, and adipose tissue for each woman. Associations between histologic metrics and breast cancer incidence were assessed in multivariable Cox proportional hazard regression models with age as the time-scale. Analyses were performed overall and following stratification by age at study entry and menopausal status. Models were adjusted for race, education, parity, body mass index, smoking status, alcohol use, and whole slide tissue area.
Results
Overall, abundant stroma was associated with decreased BC risk (hazard ratio (HR) per 1 standard deviation (SD) increase = 0.55, 95% confidence interval [CI] = 0.38 to 0.80, P < 0.01). The stromal protective effect was most profound among women younger than 55 years at tissue donation (HR/1-SD = 0.45, 95% CI = 0.26 to 0.79, P < 0.01) and in premenopausal women (HR/1-SD = 0.48, 95% CI = 0.26 to 0.87, P = 0.015), irrespective of age. Elevated epithelium and adipose tissue were associated with significantly increased BC risk in these same groups. However, when including stroma and adipose tissue in the same regression model, the mutual adjustment for stromal tissue mitigated adipose-related risk in women overall (HR/1-SD = 0.26, 95% CI = 0.06 to 1.16, P = 0.077), women younger than 55 years (HR/1-SD = 0.17, 95% CI = 0.04 to 0.71, P = 0.015), and in premenopausal women (HR/1-SD = 0.16, 95% CI = 0.04 to 0.65, P = 0.01).
Conclusion
Findings from this cohort of healthy women provide insights into the role of stroma in BC histogenesis during normal homeostasis, with potential implications for BC risk prediction and risk-reduction strategies.
利益披露 Disclosure
G. S. Hendley, None..
S. Fan, None..
S. Lawrence, None..
K. Mutreja, None..
R. M. Pfeiffer, None..
M. A. Duggan, None..
G. L. Gierach, None..
J. E. Henry, None..
M. Abubakar, None.